Medicine and Dentistry
Tertiary Care
86%
Conjugate Vaccine
86%
Shigella
73%
Diarrhea
71%
Typhoid Fever
58%
Salmonella Enterica Serovar Typhi
45%
Cross Sectional Study
42%
Diseases
32%
Infection
28%
Cohort Analysis
26%
Azithromycin
24%
Immune Response
24%
Case-Control Study
24%
Household
21%
Health Care Cost
20%
Real-Time Polymerase Chain Reaction
16%
Immune Deficiency
16%
Echocardiography
15%
Odds Ratio
15%
Pediatrics
15%
Neonatal Infant
15%
Gallbladder Disease
15%
Single Drug Dose
14%
Population Research
14%
Prevalence
14%
Diagnosis
13%
Case Definition
13%
Randomized Controlled Trial
12%
Cefixime
12%
Immunocompromised Patient
12%
Hypochromic Anemia
12%
Lung Infection
12%
Urinary Tract Infection
12%
Neonates
12%
Bruton Tyrosine Kinase
12%
Salmonella Enterica Subsp. Enterica
12%
X Linked Agammaglobulinemia
12%
Multi-Drug Resistant Organisms
12%
Prospective Cohort Study
12%
Pediatrics Patient
12%
Acid Fast Bacterium
12%
Jaundice
12%
Cohort Effect
12%
Bloodstream Infection
12%
Pediatric Hematology
12%
Oncology
12%
Anomalous Pulmonary Venous Connection
12%
Drug Megadose
12%
Gastrointestinal Surgery
12%
Lung
12%
Pharmacology, Toxicology and Pharmaceutical Science
Shigella
100%
Diarrhea
83%
Typhoid Fever
57%
Salmonella Enterica Serovar Typhi
41%
Conjugate Vaccine
36%
Azithromycin
24%
Diseases
22%
Antimicrobial Resistance
20%
Rifampicin
20%
Adverse Event
12%
Immunocompromised Patient
12%
Acid Fast Bacterium
12%
Lung Infection
12%
Case-Control Study
12%
Tebipenem
12%
Ventilator Associated Pneumonia
12%
Biological Marker
12%
Meropenem
12%
Mycobacterium Tuberculosis
12%
Urinary Tract Infection
12%
Jaundice
12%
Randomized Controlled Trial
12%
Cefixime
12%
Gallbladder Disease
12%
Cross-Sectional Study
12%
Chemoprophylaxis
12%
Erythema
12%
Toxic Injury
12%
Papule
12%
Lymphadenopathy
12%
Bladder Cancer
12%
Tuberculostatic Agent
12%
Brain Hemorrhage
12%
Isoniazid
12%
Skin Defect
12%
Pustule
12%
Skin Induration
12%
Epidemiology
12%
Antibiotics
10%
Infection
9%
Bilirubin
9%
Extrapulmonary Tuberculosis
8%
Nocardiosis
8%
Enzyme-Linked Immunosorbent Assay
7%
Clinical Trial
7%
Antiinfective Agent
7%
Antibiotic Therapy
6%
Asymptomatic Infection
6%
Prevalence
6%
Gallstone
6%